Carisma Therapeutics

company

About

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

Details

Last Funding Type
Series C
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Life Science,Medical,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Carisma Therapeutics, Inc.
Also Known As
Carisma,CARMA Therapeutics

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors. Its cell therapies apply powerful chimeric antigen receptor technology and adoptive cell transfer in cancer therapy and to macrophages that infiltrate the solid tumor micro-environment that enables solid tumor patients to receive strong cellular immunotherapy and cancer treatments. The company's technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human disease.

Founded in 2016 by Michael Klichinsky and Saar Gill, Carisma Therapeutics is headquartered in Philadelphia, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$151.85M
Carisma Therapeutics has raised a total of $151.85M in funding over 2 rounds. Their latest funding was raised on Sep 21, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 21, 2022 Series C $30M 12 Detail
Mar 1, 2021 Series B $12M 12 Detail
Jan 7, 2021 Series B $47M 10 SymBiosis LLC Detail
Aug 8, 2019 Series A $6M 2 AbbVie Biotech Ventures
HealthCap
Detail
Jun 27, 2018 Series A $53M 9 AbbVie Biotech Ventures
HealthCap
Detail

Investors

Number of Lead Investors
Number of Investors
7
15
Carisma Therapeutics is funded by 15 investors. 4BIO Capital and AbbVie are the most recent investors.
Investor Name Lead Investor Funding Round
4BIO Capital Series C
AbbVie Series C
Agent Capital Series C
HealthCap Series C
Livzon Pharmaceutical Group Series C
MRL Ventures Fund Series C
Penn Medicine Co-Investment Program Series C
Pictet Alternative Advisors Series C
Solasta Ventures Series C
SymBiosis LLC Series C

Employee Profiles

Number of Employee Profiles
14
Carisma Therapeutics has 14 current employee profiles, including Executive Bruce A. Peacock
Executive
Executive
Board member
Executive
Board member